Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Curr Opin Biotechnol. 2019 Mar 5;60:146–152. doi: 10.1016/j.copbio.2019.01.013

Table 2.

Studies Utilizing Induced BBB Disruption Neuropathology Particle Type Therapeutic Payload
Timbie KF et al. [35] F98 Glioma Pegylated Polyaspartic acid Cisplatin
Coluccia D et al. [32] U251 GBM Peptide targeting Au NC Cisplatin
Rodríguez-Frutos B et al. [39] Subcortical Stroke Lipid Microbubbles BDNF
Wang H-B et al. [40] MCAO Stroke Lipid Microbubbles pVEGF
Long L et al. [49] 6-OHDA, PD Pegylated Liposomes pNrf2
Mead BP et al. [34] 6-OHDA, PD Pegylated-PEI pGDNF

NC=nanocarrier, PEI=poly(ethyleneimine), p=plasmid, BDNF= Brain-derived neurotrophic factor, VEGF=vascular endothelial growth factor, Nrf2=nuclear factor erythroid 2-related factor 2, GDNF=glial cell-derived neurotrophic factor.